Insider Trading Alert - LPLA, VAR, AMP, AMTD And WEX Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Tuesday, Dec. 24, 2013, 63 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $3,759.88 to $2,069,942.45.

Highlighted Stocks Traded by Insiders:

LPL Financial Holdings (LPLA) - FREE Research Report

Putnam James S who is Director at LPL Financial Holdings sold 30,000 shares at $46.00 on Dec. 24, 2013. Following this transaction, the Director owned 164,280 shares meaning that the stake was reduced by 15.44% with the 30,000-share transaction.

The shares most recently traded at $46.98, up $0.98, or 2.09% since the insider transaction. Historical insider transactions for LPL Financial Holdings go as follows:

  • 4-Week # shares sold: 60,000
  • 12-Week # shares sold: 121,000
  • 24-Week # shares sold: 121,000

The average volume for LPL Financial Holdings has been 537,400 shares per day over the past 30 days. LPL Financial Holdings has a market cap of $4.8 billion and is part of the financial sector and financial services industry. Shares are up 65.98% year-to-date as of the close of trading on Tuesday.

LPL Financial Holdings Inc. provides an integrated platform of brokerage and investment advisory services to independent financial advisors and financial advisors at financial institutions in the United States. The stock currently has a dividend yield of 1.63%. The company has a P/E ratio of 28.5. Currently there are 2 analysts that rate LPL Financial Holdings a buy, 1 analyst rates it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LPLA - FREE

TheStreet Quant Ratings rates LPL Financial Holdings as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, good cash flow from operations, solid stock price performance and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full LPL Financial Holdings Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Varian Medical Systems (VAR) - FREE Research Report

Verhoef Clarence R who is SVP, Finance, Corp Controller at Varian Medical Systems sold 1,297 shares at $76.13 on Dec. 24, 2013. Following this transaction, the SVP, Finance, Corp Controller owned 1,908 shares meaning that the stake was reduced by 40.47% with the 1,297-share transaction.

The shares most recently traded at $76.72, up $0.59, or 0.77% since the insider transaction. Historical insider transactions for Varian Medical Systems go as follows:

  • 4-Week # shares sold: 14,229
  • 12-Week # shares sold: 17,201
  • 24-Week # shares sold: 24,250

The average volume for Varian Medical Systems has been 776,100 shares per day over the past 30 days. Varian Medical Systems has a market cap of $8.1 billion and is part of the health care sector and health services industry. Shares are up 9.24% year-to-date as of the close of trading on Tuesday.

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy worldwide. The company has a P/E ratio of 19.3. Currently there are 6 analysts that rate Varian Medical Systems a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VAR - FREE

TheStreet Quant Ratings rates Varian Medical Systems as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year, expanding profit margins and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Varian Medical Systems Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Ameriprise Financial (AMP) - FREE Research Report

Stewart David Kent who is Sr Vice Pres and Controller at Ameriprise Financial sold 1,000 shares at $111.50 on Dec. 24, 2013. Following this transaction, the Sr Vice Pres and Controller owned 18,543 shares meaning that the stake was reduced by 5.12% with the 1,000-share transaction.

The shares most recently traded at $113.58, up $2.08, or 1.83% since the insider transaction. Historical insider transactions for Ameriprise Financial go as follows:

  • 4-Week # shares sold: 25,798
  • 12-Week # shares sold: 69,326
  • 24-Week # shares sold: 145,861

The average volume for Ameriprise Financial has been 1.1 million shares per day over the past 30 days. Ameriprise Financial has a market cap of $22.0 billion and is part of the financial sector and financial services industry. Shares are up 80.23% year-to-date as of the close of trading on Tuesday.

Ameriprise Financial, Inc., through its subsidiaries, provides a range of financial products and services in the United States and internationally. The stock currently has a dividend yield of 1.84%. The company has a P/E ratio of 16.7. Currently there are 4 analysts that rate Ameriprise Financial a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AMP - FREE

TheStreet Quant Ratings rates Ameriprise Financial as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, solid stock price performance, compelling growth in net income and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Ameriprise Financial Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TD Ameritrade Holding Corporation (AMTD) - FREE Research Report

Moglia Joseph H who is Director at TD Ameritrade Holding Corporation sold 35,978 shares at $30.32 on Dec. 24, 2013. Following this transaction, the Director owned 847,814 shares meaning that the stake was reduced by 4.07% with the 35,978-share transaction.

The shares most recently traded at $30.36, up $0.04, or 0.12% since the insider transaction. Historical insider transactions for TD Ameritrade Holding Corporation go as follows:

  • 4-Week # shares sold: 5.6 million
  • 12-Week # shares sold: 5.6 million
  • 24-Week # shares sold: 5.7 million

The average volume for TD Ameritrade Holding Corporation has been 2.2 million shares per day over the past 30 days. TD Ameritrade Holding Corporation has a market cap of $16.8 billion and is part of the financial sector and financial services industry. Shares are up 81.08% year-to-date as of the close of trading on Tuesday.

TD Ameritrade Holding Corporation provides securities brokerage services and technology-based financial services to retail investors, traders, and independent registered investment advisors (RIAs) in the United States. The stock currently has a dividend yield of 1.58%. The company has a P/E ratio of 24.9. Currently there are 7 analysts that rate TD Ameritrade Holding Corporation a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AMTD - FREE

TheStreet Quant Ratings rates TD Ameritrade Holding Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, expanding profit margins, impressive record of earnings per share growth and compelling growth in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full TD Ameritrade Holding Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

WEX (WEX) - FREE Research Report

Maxsimic David D who is President, International at WEX sold 1,835 shares at $99.50 on Dec. 24, 2013. Following this transaction, the President, International owned 15,300 shares meaning that the stake was reduced by 10.71% with the 1,835-share transaction.

The shares most recently traded at $100.24, up $0.74, or 0.74% since the insider transaction. Historical insider transactions for WEX go as follows:

  • 4-Week # shares sold: 5,035
  • 12-Week # shares sold: 38,079
  • 24-Week # shares sold: 75,847

The average volume for WEX has been 179,200 shares per day over the past 30 days. WEX has a market cap of $3.9 billion and is part of the services sector and diversified services industry. Shares are up 32.53% year-to-date as of the close of trading on Tuesday.

WEX Inc. provides corporate card payment solutions in North and South America, the Asia Pacific, and Europe. It operates in two segments, Fleet Payment Solutions and Other Payment Solutions. The company has a P/E ratio of 27.2. Currently there are 3 analysts that rate WEX a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WEX - FREE

TheStreet Quant Ratings rates WEX as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, compelling growth in net income, solid stock price performance and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full WEX Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

3 Things Investors Must Know for Monday

3 Things Investors Must Know for Monday

Street Stats: The Mid-Term Elections May Be a Rollercoaster Ride for Investors

Street Stats: The Mid-Term Elections May Be a Rollercoaster Ride for Investors

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric